AI주식인사이트AI Stock Insight
C

하이퍼코퍼레이션

065650KOSDAQ

53.9 / 100

Reference Date: 2026-09-08

Financial Score17.5 / 40
News Sentiment14.4 / 25
Momentum8.0 / 20
Disclosure14.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 8.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hyper Corporation operates three main business divisions: Commerce, Biopharma, and Tech. The Commerce division sells PC peripherals and household products, while the Biopharma division develops innovative drugs, including anti-inflammatory treatments, Alzheimer's therapies, and a non-opioid painkiller (MDR-652). The company is expanding its market through new ventures like the early dementia diagnostic kit QPLEX Alz Plus and the EcoVacs brand, driving revenue growth.

Number of Employees

83people

Average Salary

33.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
1.12Industry Average 1.204.0Point

In line with industry avg

ROE
-4.61Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
39.24Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲21.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼159.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -103.0% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 1Negative 1Average Sentiment Score 57.5

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 1,566Won52-week high 4,57552-week low 1,476
1-month return1.0Point

1m -8.58% (falling)

Volume trend6.0Point

Volume surge

Detailed Disclosure

7 totalPositive 2Neutral 5Negative 0
  • Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-09-03
  • Neutral주식등의대량보유상황보고서(일반)2026-09-02
  • Positive[기재정정]주요사항보고서(유상증자결정)2026-08-27
  • Neutral철회신고서2026-08-27
  • Positive기타주요경영사항 (유상증자결정(주주배정후 실권주 일반공모)철회)2026-08-27